Arka Publishing Company
Canon Journal of Medicine
2676-5446
2716-991X
2
1
2021
12
01
Canon Journal of Medicine: Developing Editorial Policies and Recommence of Publication
1
2
EN
Mohamad Amin
Pourhoseingholi
0000-0002-0121-8031
Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
aminphg@gmail.com
Seyed Amir Ahmad
Safavi-Naini
0000-0001-9295-9283
National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Shahid Beheshti University of Medical Science, Tehran, Iran.
amirsafavi@sbmu.ac.ir
Mohammad Hossein
Khosravi
0000-0003-0426-5092
Department of Neurosurgery, Firoozgar Hospital, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
dr.mhkhosravi@gmail.com
10.30477/cjm.2021.300766.1022
Canon Journal of Medicine (CJM) is open access, peer-review, online journal published quarterly in general medicine and medical science. After a one-year pause in publication, from December 2021, Canon Journal of Medicine will recommence publication of scientific articles with a new Editor-in-Chief (EIC) and Editorial Board.<br />Since a high standard of ethical consideration and transparent publication is essential for medical journalism, we have made considerable changes to the editorial policies. Changes were made aligning the CJM policies with the international committee of medical journal editors (ICMJE) recommendations. Here are some critical approaches we have taken: (1) Publication of peer-review content along with the article. (2) Four reviewers for each manuscript (3) Clear guidelines. (4) Contract for Editors. (5) Permissions and Ethical Consideration Forms. (6) Social Responsibilities.
Scholarly Communication,Peer Review Research,Editorial Policies,ethics
https://www.canonjm.com/article_135333.html
https://www.canonjm.com/article_135333_84f0c614079a1520e12bbfb7d5dfe42d.pdf
Arka Publishing Company
Canon Journal of Medicine
2676-5446
2716-991X
2
1
2021
12
01
COVID-19 Pandemic and the Incidence of Kawasaki Disease in Pediatric Patients
3
3
EN
Mohammed Hosein
Amirzade-Iranaq
0000-0001-8095-0337
Department of Research, Arka Education and Clinical Research Consultants, Tehran, Iran.
h.amirzade@gmail.com
10.30477/cjm.2020.115083
COVID-19,SARS-CoV-2,children,Kawasaki disease
https://www.canonjm.com/article_115083.html
https://www.canonjm.com/article_115083_08822fba968f92079d82045a456fc211.pdf